Wockhardt Limited
NSE: WOCKPHARMA | Information Technology
Market Fundamentals
Stock Intelligence & News
Wockhardt Limited
Wockhardt Limited has informed the Exchange about Credit Rating |SUBJECT: Credit Rating
Read Full Analysis →Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?
Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by strong earnings reports, a fall in oil prices, and renewed market optimism. Key gainers included Coforge, SRF, and Wockhardt, driven by significant profit increases and strategic investments.
Read Full Analysis →Top Gainers & Losers on May 5: Wockhardt, Tata Tech, Gabriel India, Dabur, Adani Green Energy among top gainers
On May 5, Indian stocks fluctuated as US-Iran tensions affected market sentiment. The Nifty 50 closed up 0.30% after recovering from lows, while the Sensex declined 0.26%. Broader indices gained, but rising oil prices pose inflation risks for India's economy.
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Wockhardt shares surge over 12% to 9-month high as company swings to profit in Q4
Wockhardt's shares surged 12.55% to ₹1,604 following a profitable Q4FY26 with a net profit of ₹164 crore. Strong revenue growth from biotech and emerging markets fueled performance, with full-year revenue rising to ₹3,373 crore and EBITDA increasing by 51%.
Read Full Analysis →Smallcap winners! Wockhardt, Tata Tech, CAMS, other stocks rally up to 11% despite overall market weakness
Smallcap stocks outperformed on Tuesday despite weak broader markets, with Wockhardt, Tata Tech and CAMS gaining up to 11% on strong Q4 earnings. While Nifty 50 slipped below 24,000 amid global concerns, improving momentum and technical indicators signal potential continued strength in the smallcap segment, according to Emkay.
Read Full Analysis →Wockhardt shares jump 9% after strong Q4 turnaround, robust FY26 growth
Wockhardt shares saw a significant jump on Tuesday. The pharmaceutical company reported a strong turnaround in its March quarter performance. Net profit turned positive, and revenue saw a substantial increase. Full-year earnings also showed improvement. Biotech operations were a key growth driver, with expansion in emerging markets. The company also expanded its product pipeline with new filings and approvals.
Read Full Analysis →Wockhardt Limited
Pursuant to Regulation 30 of the Listing Regulations, please find enclosed Press Release on theAudited Financial Results (Standalone and Consolidated) for the quarter and the financial yearended 31st March, 2026. |SUBJECT: Press Release
Read Full Analysis →Wockhardt Limited
Board Meeting Intimation |Meeting Date: 04-May-2026
Read Full Analysis →Wockhardt Limited
Board Meeting Intimation |Meeting Date: 04-May-2026
Read Full Analysis →Wockhardt Limited
Board Meeting Intimation |Meeting Date: 04-May-2026
Read Full Analysis →Get instant alerts when WOCKPHARMA breaks news
Join investors who track Wockhardt Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for WOCKPHARMA?
WOCKPHARMA is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Wockhardt Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding WOCKPHARMA to your custom watchlist.